There is a version of the Ozempic story that gets told a lot. Person starts semaglutide, appetite drops dramatically, weight comes off faster than anything they have tried before, and the before and after photos look remarkable.
What gets told less often is what is actually happening inside that transformation — specifically, how much of the weight being lost is fat, how much is muscle, and what the difference means for how your body looks, functions and performs once you reach your goal weight.
This is not a blog about whether you should take Ozempic. That is a medical conversation. This is about body composition — what it means, why it matters more than the number on the scale, and what you can do to protect it if you are currently taking semaglutide or any other GLP-1 medication.
Weight Loss and Body Composition Are Not the Same Thing
This distinction is fundamental and almost universally overlooked in conversations about weight loss medication.
Weight loss simply means the number on the scale has gone down. Body composition describes the ratio of fat to lean tissue that makes up your body — and it is body composition, not body weight, that determines how you look, how you feel, how your metabolism functions, and how healthy you actually are.
Two people can lose exactly the same amount of weight and end up with completely different bodies depending on how much of what they lost was fat versus muscle. The person who lost 15kg of predominantly fat, with muscle preserved, will look leaner, feel stronger, and have a significantly better metabolic outlook than the person who lost 15kg of mixed fat and muscle — even though the scale shows identical numbers.
Ozempic moves the scale. It does not automatically improve body composition. Those are different outcomes, and understanding the difference is the starting point for getting the most out of any weight loss process.
What Semaglutide Does to Your Body Composition
GLP-1 receptor agonists create weight loss by suppressing appetite and reducing overall calorie intake. The body, now running in a sustained calorie deficit, draws on stored tissue for energy. In an ideal scenario, that tissue would be almost entirely fat. In practice, the body does not work that selectively.
Clinical research on semaglutide and body composition — including data from the STEP trials — shows that lean mass loss is a consistent feature of GLP-1-driven weight loss in the absence of resistance training and adequate protein intake. Estimates of the proportion of weight lost that comes from lean tissue rather than fat vary across studies, but figures in the range of 25 to 40 percent are frequently cited in the literature.
To put that in concrete terms: someone losing 20kg on semaglutide without structured training and protein support could be losing 5 to 8kg of muscle alongside the fat. That is a significant amount of lean tissue with real and lasting consequences for metabolism, physical function and long-term weight maintenance.
The informal term that has emerged for the resulting appearance — Ozempic body — describes exactly this outcome. Individuals who have lost substantial weight on GLP-1 medication without training often report looking and feeling softer than expected at their goal weight, with less definition and muscle tone than the amount of weight lost would suggest. This is body composition loss in practice.
Why Muscle Loss Matters More Than Most People Realise
Your metabolism. Muscle is the most metabolically active tissue in the body. It is the primary driver of how many calories you burn at rest — your basal metabolic rate. Lose significant lean mass and your resting metabolism slows proportionally. This creates a compounding problem: you reach your goal weight with a lower metabolic rate than you started with, meaning your body now requires fewer calories to maintain weight than it did before you began. When appetite returns after stopping medication, the gap between what you want to eat and what your body needs becomes the primary driver of weight regain.
How your body looks. Fat loss without muscle preservation produces a result that is smaller but not necessarily leaner. The visible muscle definition — the shoulder shape, the abdominal outline, the leg musculature — that most people associate with a transformed physique comes from having lean muscle underneath reduced body fat. Without the muscle, reduced body fat simply produces a softer, less defined appearance regardless of how much weight has been lost.
Physical function and long-term health. Muscle mass is directly associated with functional strength, bone density, injury resilience, posture and metabolic health. These matter beyond aesthetics. For people over 40, where age-related muscle loss is already a background process, losing additional lean mass during GLP-1 treatment can meaningfully accelerate physical decline that takes years to reverse.
The Protein Problem on Semaglutide
Understanding why muscle loss is so common on GLP-1 drugs requires understanding what the drugs do to eating patterns — and specifically to protein intake.
Semaglutide dramatically reduces overall appetite. People eat less food across the board. When total food intake drops sharply — often to 1,000 to 1,400 calories per day on higher doses — hitting adequate protein targets becomes genuinely difficult.
The minimum protein intake needed to support muscle preservation during a calorie deficit is generally cited at 1.6g per kilogram of bodyweight per day. For active individuals and those over 40, that figure rises toward 2.0g or above. For someone weighing 80kg, that is 128 to 160g of protein every day — a target that is challenging even with a normal appetite, and considerably harder when you have very little interest in eating.
The practical consequence is that most people on semaglutide are consuming protein well below what is needed to protect their lean mass — not through poor choices, but because reduced appetite affects all food intake indiscriminately. Protein does not get special treatment just because it is important.
How to Protect Your Muscle on Ozempic
The good news is that muscle loss during GLP-1 treatment is not inevitable. It is a known risk with known solutions — and both of them are straightforward.
Progressive resistance training. This is non-negotiable for anyone serious about body composition during significant weight loss. Strength training sends a direct anabolic signal to the body — a physiological instruction that muscle tissue is needed and should be maintained. Without that signal, the body has no reason to prioritise lean mass during a deficit. With it, muscle protein synthesis is upregulated and lean tissue is protected even under significant calorie restriction.
Two to three strength and conditioning sessions per week built around compound movements is the minimum effective dose. Squats, deadlifts, rows, pressing variations — exercises that recruit multiple muscle groups simultaneously and produce the strongest anabolic response. This is not about training for aesthetics, though that is a natural byproduct. It is about sending the right signal to a body that is losing weight rapidly and needs to know what to hold on to.
Deliberate protein prioritisation. Given that reduced appetite affects all eating, protein needs to be prioritised consciously and consistently — not squeezed in as an afterthought. In practical terms this means eating protein first at every meal before anything else, choosing high-density protein sources that deliver maximum protein per calorie — eggs, Greek yoghurt, chicken, fish, cottage cheese, quality protein supplements — and tracking protein intake at least periodically to confirm that targets are being met rather than assumed.
For most people on semaglutide, a high-quality protein supplement is not a luxury but a practical necessity. When appetite is suppressed and food volume is low, a shake delivering 25 to 30g of protein in a small volume makes hitting daily targets achievable in a way that whole food alone often does not.
Managing Training on Reduced Calories
One practical reality of training while on GLP-1 medication is that performance will be affected, particularly in the earlier weeks of treatment.
Significantly reduced calorie intake means reduced energy availability for training. Strength numbers may drop temporarily. Sessions may feel harder than expected for the effort being applied. Nausea — common in the early weeks of semaglutide use — can be worsened by high-intensity training, particularly close to eating.
The appropriate response to this is to reduce training intensity and volume initially and build progressively as the body adapts. Three moderate strength sessions per week will consistently outperform five aggressive sessions for muscle preservation in a low-calorie state. More, done poorly and inconsistently, produces worse outcomes than less, done well and regularly.
As a personal trainer working with clients on GLP-1 medications, the programme adjustments that matter most in the early weeks are reducing session volume, avoiding very high-intensity conditioning work that compounds nausea, spacing training away from eating windows, and building back to full intensity as side effects settle — typically within four to eight weeks of starting the medication.
Body Composition Monitoring — What to Track
The most important practical shift for anyone taking Ozempic who cares about body composition is to stop using the scale as the primary measure of progress and start monitoring lean mass and body fat separately.
A scale weight decrease tells you that total mass has reduced. It tells you nothing about what has been lost. Body composition tracking — through DEXA scanning, body fat callipers, or circumference measurements combined with progress photography — gives a genuinely useful picture of how the ratio of fat to muscle is changing over time.
This matters because the goal is not simply to lose weight. It is to arrive at a specific body composition — leaner, stronger, and more metabolically healthy — and the only way to know whether you are achieving that is to measure what actually matters.
Conclusion
Ozempic can be a powerful tool in a weight loss process. But the outcome it produces depends almost entirely on what happens alongside it — specifically whether the lean muscle that determines your metabolism, your physique and your long-term results is being protected or lost.
The truth about Ozempic body composition is straightforward: the drug creates the deficit, but training and protein determine what the body does with it. Fat loss with muscle preservation requires both. Weight loss without them produces a result that is lighter on the scale but not genuinely transformed.
If you are currently taking semaglutide and want a programme built specifically around protecting your body composition throughout the process, book a free consultation with Julian Ernst at Tempo Performance. Private studio in Fitzrovia, three minutes from Great Portland Street. Online training available worldwide.